Loading...
HER2 Status by Standardized Immunohistochemistry and Silver-Enhanced In Situ Hybridization in Korean Breast Cancer
PURPOSE: Amplification of the human epidermal growth factor receptor 2 (HER2) gene occurs in 18% to 20% of breast cancers, and it is recognized as a prognostic and predictive marker. We investigated the HER2 status in Korean breast cancer by immunohistochemistry (IHC) and silver-enhanced in situ hyb...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Korean Breast Cancer Society
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3542844/ https://ncbi.nlm.nih.gov/pubmed/23346165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2012.15.4.381 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|